Skip to Content
Merck

Skip To

3951

Periodic Acid Solution

1 g/dL in deionized water

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice

About This Item

NACRES:
NA.47
PubChem Substance ID:
UNSPSC Code:
12352106
MDL number:
Pricing and availability is not currently available.
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

solution

Quality Level

shelf life

expiry date on label

reaction suitability

reagent type: oxidant

IVD

for in vitro diagnostic use

concentration

1 g/dL in deionized water

pH

1.77

application(s)

hematology
histology

shipped in

wet ice

storage temp.

2-8°C

SMILES string

OI(O)(O)(O)(O)=O

InChI

1S/H5IO6/c2-1(3,4,5,6)7/h(H5,2,3,4,5,6,7)

InChI key

TWLXDPFBEPBAQB-UHFFFAOYSA-N

Application

For use in procedure no. 395 for Periodic Acid-Schiff (PAS) and Silver Stain Procedure No. HT100.


Still not finding the right product?

Explore all of our products under Periodic Acid Solution


pictograms

Corrosion

signalword

Danger

hcodes

Hazard Classifications

Aquatic Chronic 3 - Eye Dam. 1 - Skin Corr. 1

Storage Class

8B - Non-combustible corrosive hazardous materials

wgk

WGK 2

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Sonja Frimmel et al.
Journal of ophthalmic & vision research, 12(2), 175-182 (2017-05-26)
Diabetic retinopathy is a leading cause of vision loss. There is a great need for early diagnosis prior to the occurrence of irreversible structural damages. Expression of endothelial adhesion molecules is observed before the onset of diabetic vascular damage; however
Allison M Bradbury et al.
Human gene therapy, 29(7), 785-801 (2018-01-11)
Globoid cell leukodystrophy (GLD), or Krabbe disease, is an inherited, neurologic disorder that results from deficiency of a lysosomal enzyme, galactosylceramidase. Most commonly, deficits of galactosylceramidase result in widespread central and peripheral nervous system demyelination and death in affected infants
Allison M Bradbury et al.
Journal of neuroscience research, 94(11), 1007-1017 (2016-09-18)
Globoid cell leukodystrophy (GLD), or Krabbe's disease, is a debilitating and always fatal pediatric neurodegenerative disease caused by a mutation in the gene encoding the hydrolytic enzyme galactosylceramidase (GALC). In the absence of GALC, progressive loss of myelin and accumulation



Questions

  1. is 1 g/dL of periodic acid solution the same as 0.1%? Or do I need to dilute it to obtain 0.1%?

    1 answer
    1. The designation 'g/dL' represents grams per deciliter. A deciliter is the equivalent of 100 mL. A 1 g/dL solution is 1g/100 mL or 1%. A 0.1% solution would require dilution with 9 parts of the approriate solvent, in this case water, to 1 part of this product.

      Helpful?

Reviews

No rating value

Active Filters